多年来,国外对儿童弱视患者的治疗,一直采用以遮盖疗法为主的综合疗法,但遮盖疗法对9岁以上的儿童几乎无效,采用其他疗法也效果不佳。近几年来,随着弱视基础研究新的突破,以改善大脑皮层视中枢发育不良为突破点,选用对中枢神经有作用的药物左旋多巴内服治疗弱视。经观察,能改善 Over the years, treatment of children with amblyopia in children has been used to cover therapies based comprehensive therapy, but the cover therapy for children over the age of 9 is almost ineffective, the use of other therapies are also ineffective. In recent years, with a new breakthrough in basic research of amblyopia, in order to improve the cortical visual center dysplasia as a breakthrough point, the choice of central nervous system drug L-Dopa oral treatment of amblyopia. After observation, can improve